[The new frontier of antithrombotic therapy: ASA + warfarin, the ideal solution?]. / La nuova frontiera della terapia antitrombotica: ASA + warfarin, la soluzione ideale?

ABSTRACT

In the medical literature reports are accumulating a number of case reports suggesting the potential efficacy and safety of the combination of low-dose aspirin and warfarin to improve the efficacy of antithrombotic therapy in several clinical conditions, ranging from unstable angina to myocardial infarction. The advantages deriving from such a combination have to be considered together with its hemorrhagic risk. Thus the efficacy of such a treatment has to be proved by large clinical trials before the use of this potentially dangerous therapy can be transferred into common clinical practice.